Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1574892816666210728122304 http://scihub22266oqcxt.onion/10.2174/1574892816666210728122304 34323199!ä!34323199 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Recent+Pat+Anticancer+Drug+Discov 2022 ; 17 (2): 204-213 Nephropedia Template TP {{tp|p=34323199|t=2022. The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations |pdf=|usr=}}{{34323199}} gab.com Text The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations JO: Recent Pat Anticancer Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=34323199 #FOAvip BACKGROUND: The use of health-related applications (apps) on smartphones has become widespread. This is especially of value during the ongoing SAR-COV-2 pandemic, where accessibility to health care services has been greatly limited. Patients with free access to apps can obtain information to improve their understanding and management of health issues. Currently, there are cancer-related apps available on iPhones and androids. However, there are no guidelines to control these apps and ensure their quality. Furthermore, these apps may significantly modify the patients' perception and knowledge about drug-related health services. OBJECTIVES: The aim of this study was to assess the convenience, quality, safety and efficacy of apps for cancer patient care. METHODS: The study was conducted by searching all apps related to cancer care on both Google Play Store and Apple iTunes Store. A detailed assessment was then performed using the mobile application rating scale (MARS) and risk assessment tools. RESULTS: The results indicated that on a scale from 1-5, 47% of the apps were rated >/= 4. The MARS assessment of the apps yielded an overall quality rating of 3.38 +/- 0.9 (mean +/- SD). The visual appeal of the app was found to have a significant effect on app functionality and user engagement. The potential benefits of these apps come with challenges and limitations. Patents related to smartphone applications targeting patients were also discussed. CONCLUSION: We recommend a greater emphasis toward producing evidence-based apps. These apps should be rigorously tested, evaluated and updated by experts, particularly clinical pharmacists. Also, these apps may alter patient attitudes toward services provided by physicians and pharmacists. Finally, these apps should not replace in-person interactive health services. Twit Text FOAVip The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations ????Recent Pat Anticancer Drug Discov http://www.kidney.de/pget.php?&tw=1&pmid=34323199 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34323199 #FOAvip English Wikipedia <ref>{{Cite pmid|34323199}}</ref> The Validity of Mobile Applications to Facilitate Patient Care Provided to Cancer Patients: Opportunities and Limitations #MMPMID34323199 Amawi H; Al-Azzam S; Alzanati T; Altamimi N; Hammad A; Alzoubi KH; Ashby CR; Tiwari AK Recent Pat Anticancer Drug Discov 2022[]; 17 (2): 204-213 PMID34323199show ga BACKGROUND: The use of health-related applications (apps) on smartphones has become widespread. This is especially of value during the ongoing SAR-COV-2 pandemic, where accessibility to health care services has been greatly limited. Patients with free access to apps can obtain information to improve their understanding and management of health issues. Currently, there are cancer-related apps available on iPhones and androids. However, there are no guidelines to control these apps and ensure their quality. Furthermore, these apps may significantly modify the patients' perception and knowledge about drug-related health services. OBJECTIVES: The aim of this study was to assess the convenience, quality, safety and efficacy of apps for cancer patient care. METHODS: The study was conducted by searching all apps related to cancer care on both Google Play Store and Apple iTunes Store. A detailed assessment was then performed using the mobile application rating scale (MARS) and risk assessment tools. RESULTS: The results indicated that on a scale from 1-5, 47% of the apps were rated >/= 4. The MARS assessment of the apps yielded an overall quality rating of 3.38 +/- 0.9 (mean +/- SD). The visual appeal of the app was found to have a significant effect on app functionality and user engagement. The potential benefits of these apps come with challenges and limitations. Patents related to smartphone applications targeting patients were also discussed. CONCLUSION: We recommend a greater emphasis toward producing evidence-based apps. These apps should be rigorously tested, evaluated and updated by experts, particularly clinical pharmacists. Also, these apps may alter patient attitudes toward services provided by physicians and pharmacists. Finally, these apps should not replace in-person interactive health services. |*COVID-19[MESH] |*Mobile Applications[MESH] |*Neoplasms/therapy[MESH] |Humans[MESH] |Patents as Topic[MESH] |Patient Care[MESH]The Validity of Mobile Applications to Facilitate Patient Care Provide(epmc).pdf DeepDyve Pubget Overpricing